PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 102 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $169,000 | -63.5% | 160,880 | +2.5% | 0.00% | -100.0% |
| Q4 2015 | $463,000 | -6.5% | 156,940 | +0.3% | 0.00% | 0.0% |
| Q3 2015 | $495,000 | -47.8% | 156,541 | -2.2% | 0.00% | 0.0% |
| Q2 2015 | $948,000 | -8.1% | 160,074 | +66.0% | 0.00% | 0.0% |
| Q1 2015 | $1,031,000 | +14.2% | 96,455 | +0.3% | 0.00% | 0.0% |
| Q4 2014 | $903,000 | +20.9% | 96,152 | -1.2% | 0.00% | 0.0% |
| Q3 2014 | $747,000 | -13.3% | 97,327 | +1.4% | 0.00% | 0.0% |
| Q2 2014 | $862,000 | +171.1% | 95,943 | +61.2% | 0.00% | – |
| Q1 2014 | $318,000 | +116.3% | 59,502 | +1.7% | 0.00% | – |
| Q4 2013 | $147,000 | -8.1% | 58,487 | -0.6% | 0.00% | – |
| Q3 2013 | $160,000 | -20.4% | 58,819 | +5.8% | 0.00% | – |
| Q2 2013 | $201,000 | – | 55,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,484,649 | $7,330,000 | 8.59% |
| Avoro Capital Advisors LLC | 5,144,916 | $15,178,000 | 5.23% |
| Broadfin Capital, LLC | 6,090,829 | $17,968,000 | 1.10% |
| Aisling Capital LLC | 2,010,000 | $5,930,000 | 1.02% |
| Healthcare Value Capital, LLC | 150,000 | $443,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 434,300 | $1,281,000 | 0.61% |
| WALL STREET ASSOCIATES | 696,300 | $2,054,000 | 0.58% |
| SEARLE & CO. | 172,500 | $500,000 | 0.48% |
| Elk Creek Partners, LLC | 2,253,667 | $6,648,000 | 0.47% |
| KOPP INVESTMENT ADVISORS LLC | 315,293 | $931,000 | 0.46% |